Health Trials

Relapsed or Refractory Autoimmune Cytopenias

1

Review clinical trials related to Relapsed or Refractory Autoimmune Cytopenias. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias

The Phase 1 is to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of RXIM002 in patients with relapsed or refractory autoimmune cytopenias.

Participants needed: 27
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: RiboX Therapeutics Ltd.Updated: Aug 14, 2026
Eligibility criteria

18-75 years of age [+2]

Allergy or hypersensitivity to messenger ribonucleic acid (mRNA) vaccines or oth... [+2]

Read more